10x Genomics, Inc.
TXG
$9.42
$0.313.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -34.36M | -49.03M | -35.75M | -37.90M | -59.95M |
| Total Depreciation and Amortization | 9.81M | 10.56M | 10.75M | 10.90M | 11.49M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.62M | 33.09M | 33.65M | 38.56M | 39.03M |
| Change in Net Operating Assets | 28.28M | -1.38M | 12.99M | -4.07M | -6.30M |
| Cash from Operations | 34.35M | -6.75M | 21.64M | 7.50M | -15.73M |
| Capital Expenditure | -1.89M | -2.72M | -3.89M | -2.88M | -2.91M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -48.88M | 271.00K | 14.83M | 13.54M |
| Cash from Investing | -1.89M | -51.59M | -3.62M | 11.95M | 10.63M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 422.00K | 4.52M | 156.00K | 4.60M | 1.64M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 422.00K | 4.52M | 156.00K | 4.60M | 1.64M |
| Foreign Exchange rate Adjustments | 114.00K | -269.00K | 156.00K | -3.00K | -48.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.99M | -54.09M | 18.34M | 24.04M | -3.50M |